Lexpos News

With Early May Bank Holiday (4 May 2026) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 May 2026, to submit their April FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division [...]

The post Extended FP34C submission deadline for prescriptions dispensed in April 2026 appeared first on Community Pharmacy England.

A report by Edge Health, sponsored by Sandoz, has examined the growing pressures on community pharmacies and the long-term sustainability of the sector. The report says that community pharmacies are facing growing operational and financial pressures, highlighting that: Increasing time is being spent by pharmacies comparing medicine prices and sourcing stock from multiple wholesalers for [...]

The post Our response to Edge Health’s report on the future of community pharmacy appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) Drug Alert Number: EL(25)A/21 Date issued: 23 April 2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of [...]

The post MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined April 2026 reimbursement prices for the following products to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant retrospective price [...]

The post Retrospective reimbursement prices for April 2026 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ramipril 1.25mg capsules. MSN/2026/022 Tier 2 – Medium impact Date of issue: 23 April 2026 There are intermittent supply issues with ramipril 1.25mg capsules until the end of May 2026. Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available [...]

The post Medicine Supply Notification: Ramipril 1.25mg capsules appeared first on Community Pharmacy England.